Comparing Cardiovascular Safety Profile Of Anti-Obesity Medications - A FAERS Database Analysis

被引：0
|
作者：
Patel, Riya
Pandya, Krutarth
Shah, Kruti
Bhakta, Shyam
机构：
来源：
OBESITY | 2023年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
429
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
  • [31] Simulating the Fiscal Impact of Anti-Obesity Medications as an Obesity Reduction Strategy
    Kabiri, Mina
    Ward, Alison Sexton
    Ramasamy, Abhilasha
    Kee, Rebecca
    Ganguly, Rahul
    Smolarz, Brian Gabriel
    Zvenyach, Tracy
    Baumgardner, James R.
    Goldman, Dana P.
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2021, 58
  • [32] Impact of Weight-Loss Medications on the Cardiovascular SystemFocus on Current and Future Anti-Obesity Drugs
    Benoit Drolet
    Chantale Simard
    Paul Poirier
    American Journal of Cardiovascular Drugs, 2007, 7 : 273 - 288
  • [33] A New Strategy for Obesity Treatment: Revealing the Frontiers of Anti-obesity Medications
    Huang, Pan-feng
    Wang, Qi-Yu
    Chen, Rong-Bin
    Wang, Ya-Di
    Wang, Yuan-Yuan
    Liu, Jiang-Hua
    Xiao, Xin-Hua
    Liao, Zhe-Zhen
    CURRENT MOLECULAR MEDICINE, 2025, 25 (01) : 13 - 26
  • [34] ANTI-OBESITY MEDICATIONS AND RELATED OSTEOARTHRITIS RISK AMONG PATIENTS WITH OBESITY
    Baser, O.
    Samayoa, G.
    Mohamed, M.
    Baser, E.
    VALUE IN HEALTH, 2024, 27 (12)
  • [35] Descriptive analysis of reported adverse events associated with anti-obesity medications using FDA Adverse Event Reporting System (FAERS) databases 2013–2020
    Abdulrahman Alsuhibani
    Marwan Alrasheed
    Musaab Gari
    Ana L. Hincapie
    Jeff Jianfei Guo
    International Journal of Clinical Pharmacy, 2022, 44 : 172 - 179
  • [36] Cardiovascular and psychiatric risk profile and patterns of use in patients starting anti-obesity drugs
    Willemen, Marjolein J. C.
    Mantel-Teeuwisse, Aukje K.
    Straus, Sabine M. J. M.
    Leufkens, Hubert G. M.
    Egberts, Antoine C. G.
    Sturkenboom, Miriam C. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (07) : 631 - 638
  • [37] Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
    Lin Zhang
    Zhi Liu
    Shenling Liao
    He He
    Mei Zhang
    European Journal of Clinical Pharmacology, 2021, 77 : 1611 - 1621
  • [38] Cardiovascular safety of long-term anti-obesity drugs in subjects with overweight or obesity: a systematic review and meta-analysis
    Zhang, Lin
    Liu, Zhi
    Liao, Shenling
    He, He
    Zhang, Mei
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (11) : 1611 - 1621
  • [39] Real-world safety profile of zanubrutinib: a disproportionality analysis based on the FAERS database
    Wang, Jiangfeng
    Zheng, Xiaochun
    Lin, Jingyang
    Huang, Jinlong
    Zhang, Miaomiao
    Huang, Ping
    Yang, Xiuli
    BMJ OPEN, 2024, 14 (10):
  • [40] PARENTAL OPINIONS OF ANTI-OBESITY MEDICATIONS FOR PEDIATRIC OBESITY AND CO-MORBIDITIES
    Hasan, Anam
    Raatz, Sarah
    Freese, Rebecca
    Bensignor, Megan
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 276 - 277
12345